CAR- T as well as mobile genetics therapies are too expensive

.Mother Nature Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and innovation transactions may supply cell genetics therapies at an affordable expense to patients around the planet.